- $103.23m
- $0.28m
- $708.06m
- 47
- 93
- 38
- 61
2020 February 1st | 2021 January 30th | 2022 January 29th | 2023 January 28th | 2024 February 3rd | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 825 | 575 | 769 | 759 | 708 |
Cost of Revenue | |||||
Gross Profit | 316 | 142 | 316 | 250 | 244 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 788 | 654 | 732 | 762 | 727 |
Operating Profit | 37.2 | -79.2 | 36.9 | -2.61 | -18.9 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 43.2 | -72.8 | 39 | 1.77 | -13.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 35.9 | -72.8 | 36.8 | 0.029 | -23.9 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 35.9 | -47.5 | 36.8 | 0.029 | -23.9 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 34.6 | -45.4 | 34.9 | 0.041 | -22.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.46 | -2.53 | 1.69 | -0.016 | 59.5 |
Dividends per Share |